TNF-α-IN-6 is primarily utilized in research settings to study the role of TNF-α (tumor necrosis factor-alpha) in various inflammatory and autoimmune diseases. It serves as a valuable tool for investigating the pathways and mechanisms involved in conditions such as rheumatoid arthritis, Crohn's disease, and psoriasis. By inhibiting TNF-α activity, this compound helps researchers understand its contribution to disease progression and explore potential therapeutic strategies. Additionally, it aids in the development of novel anti-inflammatory drugs by providing insights into the efficacy and safety of TNF-α inhibition. Its application extends to preclinical studies, where it is used to evaluate the impact of TNF-α blockade on cellular and animal models of inflammation.